What we do
News
Insights
Our work
LucidSearch
QuickAnswers

Contact Us

Search

artificial intelligence

Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - April 6th 2025

Next-Generation Diagnostics, Virtual Care, and AI-Powered Therapies Stay ahead…

Top 20 companies in AI in Healthcare space

AI in Healthcare: Navigating the Global Landscape and Strategic Insights for Pharma and Biotech Companies

Artificial Intelligence (AI) has emerged as a transformative force in the…

by Timos Papagatsias

artificial_intelligence_machine_learning

Is the FDA ready for artificial intelligence and machine learning?

Software as a Medical Device (SaMD) - FDA’s AI/ML Plan The greatest advantage…

by Yaseen Gigani

Categories

Insights
Case studies
News

Recent Posts

Public Health Weekly News -18th April 2025
Respiratory Weekly News – 18th April 2025
Vaccines Weekly Update – 18th April 2025
Rare Diseases Weekly News – April 17th 2025
Cell and Gene Therapy Weekly News – April 17th 2025

Tags

AAV and liver toxicity Alagille Syndrome Amgen aparito ASH 2022 astellas Asthma behavioral medicine Biofourmis Bluebird Bio Chinese pharma cidp clotting factor CNS dengue environment Fabry Disease generics manufacturing Glucose Monitoring H5N1 HealthTech Inherited Retinal Disorders janssen LUNG HEALTH market entry strategies mental health management mobile health Moderna mRNA Therapy neurology NFTs applications non-viral vector market nosocomial infections Octapharma OncologyInnovation opthalmology patent cliff patients positioning strategy preeclampsia rare disease clinical trials Sales force schizophrenia solutions virtual sales

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Public Health Weekly News -18th April 2025
Respiratory Weekly News – 18th April 2025
Vaccines Weekly Update – 18th April 2025
Rare Diseases Weekly News – April 17th 2025
Cell and Gene Therapy Weekly News – April 17th 2025

TAGS

AAV and liver toxicity Alagille Syndrome Amgen aparito ASH 2022 astellas Asthma behavioral medicine Biofourmis Bluebird Bio Chinese pharma cidp clotting factor CNS dengue environment Fabry Disease generics manufacturing Glucose Monitoring H5N1 HealthTech Inherited Retinal Disorders janssen LUNG HEALTH market entry strategies mental health management mobile health Moderna mRNA Therapy neurology NFTs applications non-viral vector market nosocomial infections Octapharma OncologyInnovation opthalmology patent cliff patients positioning strategy preeclampsia rare disease clinical trials Sales force schizophrenia solutions virtual sales

What we do
News
Insights
Our work
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy